Study Finds Infant Painkillers Safe, No Link to Eczema or Bronchiolitis
A comprehensive study has found that the use of common infant painkillers, paracetamol (acetaminophen) and ibuprofen, does not increase the risk of eczema or bronchiolitis in infants during their first year. This research, conducted by a team led by Professor Stuart Dalziel at the University of Auckland, followed nearly 4,000 babies in New Zealand. The study, published in The Lancet Child & Adolescent Health, involved randomly assigning infants to receive either paracetamol or ibuprofen for fever or pain relief. Researchers monitored the infants for symptoms of eczema, asthma, and bronchiolitis, and reviewed medical records to ensure accurate data collection. The findings showed no statistically significant difference in the development of eczema or bronchiolitis between the two groups, providing reassurance about the safety of these medications in early childhood. 
